Research Article
Combination of Microwave-Assisted Girard Derivatization with Ionic Liquid Matrix for Sensitive MALDI-TOF MS Analysis of Human Serum N-Glycans
Table 2
Condition optimization. MS intensity for each glycan at three different conditions and the enhancement factors (EFs).
| Glycan no. | MS intensity | Enhancement Factor | Condition 1 MW | Condition 2 SPE | Condition 3 MW + SPE | Con 3/Con 1 w/or w/o SPE | Con 3/Con 2 w/or w/o MW |
| IS | 29738 | 299037 | 682825 | 23.0 | 2.3 | G5 | 5991 | 72493 | 122582 | 20.5 | 1.7 | G8 | 2463 | 9714 | 12278 | 5.0 | 1.3 | G10 | 5328 | 56814 | 97849 | 18.4 | 1.7 | G14 | 11482 | 91319 | 227387 | 19.8 | 2.5 | G15 | 2493 | 11139 | 15844 | 6.4 | 1.4 | G17 | 2604 | 10991 | 24068 | 9.2 | 2.2 | G20 | 2377 | 31626 | 76822 | 32.3 | 2.4 | G21 | 13829 | 93595 | 270122 | 19.5 | 2.9 | G23 | 2372 | 20225 | 45111 | 19.0 | 2.2 | G25 | 2806 | 20863 | 39855 | 14.2 | 1.9 | G27 | 5192 | 32241 | 83983 | 16.2 | 2.6 | G28 | 3974 | 22301 | 57710 | 14.5 | 2.6 | G30 | 2777 | 20591 | 40422 | 14.6 | 2.0 | Ave ± STD | | | | 16.6 ± 7.0 | 2.1 ± 0.5 |
|
|
We calculated the EFs for the glycans, which were commonly assigned at the three conditions. |